Key regions: Japan, India, Italy, Brazil, South Korea
The demand for Anti-Hypertensive Drugs in Timor-Leste has been on the rise in recent years.
Customer preferences: The majority of the population in Timor-Leste is affected by hypertension, making it a significant public health concern. The increasing prevalence of hypertension has led to an increase in demand for Anti-Hypertensive Drugs. Patients in Timor-Leste prefer affordable and readily available medications that can effectively control their blood pressure.
Trends in the market: The Anti-Hypertensive Drugs market in Timor-Leste has experienced significant growth due to the increasing prevalence of hypertension. The market is dominated by generic drugs due to their affordability and accessibility. The demand for Anti-Hypertensive Drugs is expected to continue to grow in the future due to the aging population and the increasing prevalence of hypertension.
Local special circumstances: Timor-Leste is a small country with a developing economy and a limited healthcare infrastructure. The country relies heavily on imports for its pharmaceutical needs, making it vulnerable to supply chain disruptions. The lack of awareness and education about hypertension among the population is also a significant challenge in the prevention and management of hypertension.
Underlying macroeconomic factors: The economic growth in Timor-Leste has been slow due to its dependence on oil exports. The country is trying to diversify its economy by investing in agriculture and tourism. However, the COVID-19 pandemic has severely impacted the economy, leading to a decline in government revenue and an increase in unemployment. The pandemic has also disrupted the supply chain of pharmaceuticals, leading to shortages of essential medications.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
